000 | 01684 a2200481 4500 | ||
---|---|---|---|
005 | 20250513135231.0 | ||
264 | 0 | _c19980313 | |
008 | 199803s 0 0 eng d | ||
022 | _a0041-1337 | ||
024 | 7 |
_a10.1097/00007890-199802150-00015 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNoel, C | |
245 | 0 | 0 |
_aImprovement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trial. _h[electronic resource] |
260 |
_bTransplantation _cFeb 1998 |
||
300 |
_a385-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGraft Rejection _xepidemiology |
650 | 0 | 4 |
_aGraft Survival _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aKidney Transplantation _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aPentoxifylline _xtherapeutic use |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
700 | 1 | _aHazzan, M | |
700 | 1 | _aLabalette, M | |
700 | 1 | _aCoppin, M C | |
700 | 1 | _aJude, B | |
700 | 1 | _aDessaint, J P | |
700 | 1 | _aLelievre, G | |
773 | 0 |
_tTransplantation _gvol. 65 _gno. 3 _gp. 385-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007890-199802150-00015 _zAvailable from publisher's website |
999 |
_c9452951 _d9452951 |